Delivery Order SPE2DB24D9210-SPE2DB25FZMV8

Award Date 4/11/25
Potential Completion Date 4/14/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,470.90 firm fixed-price delivery order is for the supply of Armour Thyroid 120 mg tablets. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,187.40 Firm Fixed Price delivery order is for the supply of Armour Thyroid 60 mg tablets. The award is under a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,374.48 firm fixed-price delivery order is for the supply of Armour Thyroid 60 mg tablets in 100-count bottles. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to...
This federal contract award is a delivery order under a single-award indefinite delivery contract (IDC) valued at up to $499,999,999 between the Defense Logistics Agency (DLA) and the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The IDC, issued under the DLA's SPE2DB program, allows the DLA to place firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, from common medications...
This federal contract award, with ID SPE2DB20D6037|SPE2DB23FC9VR, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of Armour Thyroid 60 mg tablets, with a ceiling value of $6,089.25 and an ultimate completion date of December 8, 2022. The contract is a delivery order under a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,259.88 and covers the delivery of Armour Thyroid 120 mg tablets over a period ending on February 10, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the delivery of Armour Thyroid 120 mg tablets for a period ending on January 29, 2025, with a ceiling value of $1,049.90. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,567,823,642 units of Armour Thyroid 120 mg tablets in 100-count packages, with a ceiling value of $1,259.88 and a performance period through April 7, 2025. This contract is not associated with a set-aside program. DMS Pharmaceutical Group...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $1,259.88 and has an ultimate completion date of April 9, 2025. The contract is for the delivery of Armour Thyroid 120 mg tablets in 100-count packages. This contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery...
This federal contract award, with ID SPE2DB22D9133|SPE2DB25FYV90, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,519.76 firm fixed-price delivery order is for the supply of 4567481240 ARMOUR THYROID 120 MG TABLET 100S to support the medical needs of the Department of Defense (DoD). DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
  • SPE2DB24D9210
    Indefinite Delivery Contract
  • SPE2DB24D9210-SPE2DB25FZMV8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,259.88 firm fixed-price delivery order is for the supply of Armour Thyroid 120 mg tablets.

The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 7/11/25, 9:46 AM